Evaluation of the effects of propylisopropylacetic acid (PIA) on neuronal growth cone morphology.
Propylisopropylacetic acid (PIA) is a constitutional isomer of valproic acid (VPA). It has previously been found to be a weak antiepileptic, but in common with mood stabilizers, causes inositol depletion and growth cone spreading, suggesting the basis of a new series of mood stabilizers. To assess this possibility, we have compared the effects of racemic (R,S)-PIA and its individual enantiomers to those of the mood stabilizers lithium (Li+), VPA and carbamazepine (CBZ). Unlike Li+ and VPA, but in common with CBZ and (R,S)-PIA, neither (R)-PIA nor (S)-PIA enantiomer induces T-cell factor (TCF)-mediated gene expression. However, as seen for other mood stabilizers, both enantiomers are potent inducers of growth cone spreading. To investigate the mechanism for these effects, we examined changes in the actin cytoskeleton following drug treatment with Li+, VPA, CBZ, (R,S)-PIA or its individual enantiomers. All exhibit a redistribution of F-actin to the growth cone periphery, a feature of spread growth cones. (R,S)-PIA has the strongest effect as it also elevates F-actin polymerization at the cell periphery. This change in the actin cytoskeleton is associated with a substantial increase in F-actin-rich protrusions on the surface of the growth cone and in its close vicinity. These results demonstrate an effect of (R,S)-PIA on the neuronal actin cytoskeleton shared in common with other mood stabilizers, and suggest a potential to induce structural changes within the CNS.
Shimshoni
Jakob A
JA
Department of Pharmaceutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Dalton
Emma C
EC
Watson
Peter
P
Boris
Yagen
Y
Bialer
Meir
M
Harwood
Adrian J
AJ
D000199:Actins / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D018692:Antimanic Agents / Q000494:pharmacology; D002220:Carbamazepine / Q000494:pharmacology; D003599:Cytoskeleton / Q000187:drug effects; D005727:Ganglia, Spinal / Q000166:cytology / Q000187:drug effects; D015870:Gene Expression / Q000187:drug effects; D020439:Growth Cones / Q000187:drug effects* / Q000648:ultrastructure*; D007150:Immunohistochemistry; D018021:Lithium Chloride / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects* / Q000648:ultrastructure*; D009924:Organ Culture Techniques; D051381:Rats; D017207:Rats, Sprague-Dawley; D013237:Stereoisomerism; D013601:T-Lymphocytes / Q000502:physiology; D014635:Valproic Acid / Q000494:pharmacology*
D000199:Actins; D018692:Antimanic Agents; D002220:Carbamazepine; D014635:Valproic Acid; D018021:Lithium Chloride
FEBS Lett. 1995 Mar 13;361(1):1-7
7890024
Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8455-9
8710892
Biochem Biophys Res Commun. 2001 Jan 26;280(3):720-5
11162580
Biochem Pharmacol. 2003 Jul 15;66(2):179-89
12826261
Prog Neurobiol. 2008 Nov;86(3):281-96
18786602
Trends Neurosci. 2007 Apr;30(4):142-9
17324475
J Biol Chem. 2001 Sep 28;276(39):36734-41
11473107
CNS Neurol Disord Drug Targets. 2007 Jun;6(3):193-204
17511616
J Cell Sci. 1998 May;111 ( Pt 10):1351-61
9570753
Neurosci Lett. 2001 Oct 26;312(3):141-4
11602330
Mol Cell Neurosci. 2003 Aug;23(4):626-37
12932442
Biochem Soc Trans. 2004 Nov;32(Pt 5):799-802
15494019
J Neurosci. 2004 Jul 28;24(30):6791-8
15282284
Mol Pharmacol. 2007 Mar;71(3):884-92
17167030
J Biol Chem. 1980 Nov 25;255(22):10896-901
6253491
J Med Chem. 2007 Dec 13;50(25):6419-27
17994680
Curr Opin Psychiatry. 2007 Jan;20(1):1-7
17143074
Eur J Immunol. 1986 Jul;16(7):859-61
3013648
Mol Pharmacol. 2005 May;67(5):1426-33
15687223
Bipolar Disord. 2005 Jun;7(3):260-5
15898963
Cell. 1989 Nov 3;59(3):411-9
2553271
J Neurochem. 1999 Mar;72(3):1327-30
10037507
Biol Psychiatry. 2004 Apr 15;55(8):781-4
15050857
Braz J Psychiatry. 2004 Sep;26(3):180-8
15645064
J Cell Sci. 1999 Oct;112 ( Pt 19):3373-84
10504342
Annu Rev Cell Dev Biol. 2002;18:601-35
12142283
Biol Psychiatry. 2005 Jul 15;58(2):151-7
15922309
Methods Enzymol. 1979;58:94-109
423795
Prog Neuropsychopharmacol Biol Psychiatry. 2004 Mar;28(2):209-24
14751416
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5099-104
15044694
Mol Cell Neurosci. 2002 Jun;20(2):257-70
12093158
Biol Psychiatry. 1999 Apr 15;45(8):995-1003
10386182
Behav Pharmacol. 2007 Sep;18(5-6):419-30
17762510
Neuron. 2003 Oct 9;40(2):209-27
14556705
Nature. 2002 May 16;417(6886):292-5
12015604
Science. 1997 Mar 21;275(5307):1784-7
9065401
Hum Psychopharmacol. 2002 Oct;17(7):321-7
12415549
Int J Neuropsychopharmacol. 2004 Dec;7(4):387-90
15315719
Annu Rev Neurosci. 2005;28:251-74
16022596
Biol Psychiatry. 2004 Dec 1;56(11):868-74
15576064